What This Immunome Sale Signals Ahead of FDA Milestone
When a biotech firm nears a major FDA decision, every insider transaction can feel like a tell. This article dives in...
Biotech Stocks
Biotech Stocks page aggregates 6 articles covering catalysts, earnings moves, and company updates to help you spot opportunities and manage biotech investments more confidently.
180 articles
Many Investors Still Treating Gilead: 4 Launches This Year Could Prove Them Wrong
Gilead sits at a crossroads: the HIV backbone remains strong, but a quartet of new launches could reshape the company...
NVIDIA Jensen Huang Said AI Could Transform Life Sciences
NVIDIA’s push beyond chips is drawing investor attention to life sciences. This article breaks down what Jensen Huang...
Is This Biotech Stock After Its Massive Rally a Smart Buy?
A biotech stock can surge on hype, but smart investors dig into the data behind the rally. This guide breaks down how...
Crinetics Stock Soared This Week After Vertex Acquisition Bid
Vertex’s $10 billion cash bid for Crinetics sparked a sharp rally, lifting the stock nearly to the offer price as tra...
This $1,200 Stock Could Spark the Next Big Split
Eli Lilly's blockbuster first quarter puts the spotlight on a possible stock split as its high-priced shares approach...
Safe Amgen's Dividend? A Practical Investor's Guide
Amgen's dividend has powered income-focused portfolios for years, but regulatory and pricing challenges raise questio...
Crispr Therapeutics Viking Therapeutics: 2026 Stock Showdown
As biotech investors look to 2026, crispr therapeutics viking therapeutics presents two distinct paths: gene editing ...
Could Roivant Sciences Be a Multibagger Stock Soon
Biotech investing offers life-changing upside, but it also comes with steep risks. This guide breaks down whether cou...
Vertex Pharmaceuticals Stock Soaring: Is More Upside Ahead?
Vertex Pharmaceuticals has climbed to fresh highs, fueled by a robust cystic fibrosis portfolio and strong cash flow....
Septerna's Chief People Officer Stock Move: Investor View
A senior insider at Septerna sold nearly 12,000 shares in a single move, raising questions for investors. This articl...
MoonLake Immunotherapeutics' Sells Shares: Insider Moves Unpacked
When a company's chief financial officer sells a sizable stake, investors want to know what it means. This deep dive ...
Related Topics
#Investing (146)
#Stock Analysis (44)
#Earnings Analysis (28)
#Insider Trading (28)
#Stock Market (20)
#Portfolio Strategy (16)
#Stock Market News (16)
#Earnings (14)
#Portfolio Management (12)
#Eli Lilly (10)
#Investing Strategy (9)
#SEC Filings (7)
#risk-management (6)
#Hedge Funds (6)
#CRISPR (6)